|
| 37980250 | Contemporary Role of Lymph Node Dissection in Genitourinary Cancers: Where Are We in 2023? | Eur Urol Oncol | 2024 |
| 37747492 | [Neuro-otological manifestations in Fabry disease-a retrospective single center study]. | HNO | 2024 |
| 38056438 | Female Hyperplastic PSA-Positive Prostate Tissue in the Bladder Neck. | Urol Int | 2024 |
| 37543656 | Novel non-MRI imaging techniques for primary diagnosis of prostate cancer: micro-ultrasound, contrast-enhanced ultrasound, elastography, multiparametric ultrasound, and PSMA PET/CT. | Prostate Cancer Prostatic Dis | 2024 |
| 35976818 | Enhancing Tissue Impedance Measurements Through Modeling of Fluid Flow During Viscoelastic Relaxation. | IEEE Trans Biomed Eng | 2023 |
| 37662704 | Defining Oligometastatic Bladder Cancer: A Systematic Review. | Eur Urol Open Sci | 2023 |
| 37626918 | Effects of Scaffolds on Urine- and Urothelial Carcinoma Tissue-Derived Organoids from Bladder Cancer Patients. | Cells | 2023 |
| 38072761 | Clinical Outcomes of Enzalutamide in Metastatic Hormone-sensitive Prostate Cancer in Patients Aged <75 and â¿¥75 Years: ARCHES Post Hoc Analysis. | Eur Urol Oncol | 2023 |
| 37681920 | A Protocol for Organoids from the Urine of Bladder Cancer Patients. | Cells | 2023 |
| 37978195 | TOF<sub>IMS</sub> mass spectrometry-based immunopeptidomics refines tumor antigen identification. | Nat Commun | 2023 |
| 37770373 | Gross Hematuria Associated with Anticoagulants and Antiplatelet Drugs: Analysis of Current Treatment Standards and Relevance of Co-medication and Pharmacological Interactions. | Eur Urol Focus | 2023 |
| 37760927 | Stress Urinary Incontinence: An Unsolved Clinical Challenge. | Biomedicines | 2023 |
| 37124116 | Cystoscopic depth estimation using gated adversarial domain adaptation. | Biomed Eng Lett | 2023 |
| 37217391 | Definition and Diagnosis of Oligometastatic Bladder Cancer: A Delphi Consensus Study Endorsed by the European Association of Urology, European Society for Radiotherapy and Oncology, and European Society of Medical Oncology Genitourinary Faculty. | Eur Urol | 2023 |
| 36982302 | Differential Expression and Clinical Relevance of C-X-C Motif Chemokine Receptor 4 (CXCR4) in Renal Cell Carcinomas, Benign Renal Tumors, and Metastases. | Int J Mol Sci | 2023 |
| 37311989 | Letter to the Editor on the systematic review "Narrow band imaging versus white light cystoscopy alone for transurethral resection of non-muscle invasive bladder cancer". | World J Urol | 2023 |
| 37179240 | The Efficacy of Enzalutamide plus Androgen Deprivation Therapy in Oligometastatic Hormone-sensitive Prostate Cancer: A Post Hoc Analysis of ARCHES. | Eur Urol | 2023 |
| 37173959 | Protein Levels of Anti-Apoptotic Mcl-1 and the Deubiquitinase USP9x Are Cooperatively Upregulated during Prostate Cancer Progression and Limit Response of Prostate Cancer Cells to Radiotherapy. | Cancers (Basel) | 2023 |
| 36473782 | High-quality Transurethral Resection of Bladder Tumour Needs Additional Forms of Tumour Delineation. | Eur Urol | 2023 |
| 36915613 | Clinical outcome of biomarker-guided therapies in adult patients with tumors of the nervous system. | Neurooncol Adv | 2023 |
| 36769440 | A Peritoneal Purse-String Suture Prevents Symptomatic Lymphoceles in Retzius-Sparing Robot-Assisted Radical Prostatectomy. | J Clin Med | 2023 |
| 36710596 | Robotic radical cystectomy - more precision needed? | Curr Opin Urol | 2023 |
| 36931467 | Inceptor correlates with markers of prostate cancer progression and modulates insulin/IGF1 signaling and cancer cell migration. | Mol Metab | 2023 |
| 35907009 | Real world data on IO-based therapy for metastatic renal cell carcinoma. | J Cancer Res Clin Oncol | 2023 |
| 36274029 | Discriminative capacity of guideline recommendations in the assessment of patients with asymptomatic microhematuria. | Urol Oncol | 2023 |
| 36087070 | Impact of darolutamide on local symptoms: pre-planned and post hoc analyses of the ARAMIS trial. | BJU Int | 2023 |
| 36253307 | Re. Effect of Robot-assisted Radical Cystectomy with Intracorporeal Urinary Diversion vs Open Radical Cystectomy on 90-Day Morbidity and Mortality Among Patients with Bladder Cancer: A Randomized Clinical Trial. | Eur Urol | 2023 |
| 33402314 | Definition of a Structured Training Curriculum for Robot-assisted Radical Cystectomy with Intracorporeal Ileal Conduit in Male Patients: A Delphi Consensus Study Led by the ERUS Educational Board. | Eur Urol Focus | 2022 |
| 35740636 | Role of the Systemic Immune-Inflammation Index in Patients with Metastatic Renal Cell Carcinoma Treated with First-Line Ipilimumab plus Nivolumab. | Cancers (Basel) | 2022 |
| 35805961 | Data-Driven Identification of Biomarkers for In Situ Monitoring of Drug Treatment in Bladder Cancer Organoids. | Int J Mol Sci | 2022 |
| 35678045 | Nicotinamide-N-methyltransferase is a promising metabolic drug target for primary and metastatic clear cell renal cell carcinoma. | Clin Transl Med | 2022 |
| 35675470 | The impact of enzalutamide on quality of life in men with metastatic hormone-sensitive prostate cancer based on prior therapy, risk, and symptom subgroups. | Prostate | 2022 |
| 35798674 | En Bloc Resection of Bladder Tumours: Ready for Clinical Use? | Eur Urol Oncol | 2022 |
| 35577732 | The Accuracy of Sequential Urethral Frozen Section and its Impact on Urethral Recurrence After Radical Cystectomy. | Clin Genitourin Cancer | 2022 |
| 35466714 | Replacing Needle Injection by a Novel Waterjet Technology Grants Improved Muscle Cell Delivery in Target Tissues. | Cell Transplant | 2022 |
| 35431136 | The CAG-triplet in the androgen receptor gene and single-nucleotide polymorphisms in androgen pathway genes in patients with concomitant bladder and prostate cancer. | Urol Oncol | 2022 |
| 35697600 | EAU-EANM Consensus Statements on the Role of Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography in Patients with Prostate Cancer and with Respect to [<sup>177</sup>Lu]Lu-PSMA Radioligand Therapy. | Eur Urol Oncol | 2022 |
| 35628262 | CD24: A Marker for an Extended Expansion Potential of Urothelial Cancer Cell Organoids In Vitro? | Int J Mol Sci | 2022 |
| 35420921 | Improved Survival With Enzalutamide in Patients With Metastatic Hormone-Sensitive Prostate Cancer. | J Clin Oncol | 2022 |
| 35563359 | Elevated Expression of the Immune Checkpoint Ligand CD276 (B7-H3) in Urothelial Carcinoma Cell Lines Correlates Negatively with the Cell Proliferation. | Int J Mol Sci | 2022 |
| 35389061 | [Multiparametric MRI of the prostate]. | Urologe A | 2022 |
| 35357510 | T2 mapping for the characterization of prostate lesions. | World J Urol | 2022 |
| 35682984 | Urinary Tract Tumor Organoids Reveal Eminent Differences in Drug Sensitivities When Compared to 2-Dimensional Culture Systems. | Int J Mol Sci | 2022 |
| 36431238 | Diabetes and the Prostate: Elevated Fasting Glucose, Insulin Resistance and Higher Levels of Adrenal Steroids in Prostate Cancer. | J Clin Med | 2022 |
| 36109798 | A novel molecular signature identifies mixed subtypes in renal cell carcinoma with poor prognosis and independent response to immunotherapy. | Genome Med | 2022 |
| 36174585 | Current best practice for bladder cancer: a narrative review of diagnostics and treatments. | Lancet | 2022 |
| 35897708 | Multiparametric Classification of Non-Muscle Invasive Papillary Urothelial Neoplasms: Combining Morphological, Phenotypical, and Molecular Features for Improved Risk Stratification. | Int J Mol Sci | 2022 |
| 35960727 | Combination of PI-RADS score and mRNA urine test-A novel scoring system for improved detection of prostate cancer. | PLoS One | 2022 |
| 35925246 | [Patient-derived microtumors : Potential for therapeutic response prediction-a case study]. | Urologie | 2022 |
| 35922717 | Head-to-head comparison of biparametric versus multiparametric MRI of the prostate before robot-assisted transperineal fusion prostate biopsy. | World J Urol | 2022 |